Back
Procter & Gamble Co. Vs. Arrowhead Pharmaceuticals, Inc. Sector Stock Comparison
Sell
20
PG
Procter & Gamble Co.
Last Price:
$143.12
Seasonality Move:
2.39%
Sell
46
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$61.04
Seasonality Move:
-2.16%
Sell
20
Procter & Gamble Co. (PG)
is a Sell
Is Procter & Gamble Co. a Buy, Sell or Hold?
-
The current Procter & Gamble Co. [PG] share price is $143.12. The Score for PG is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
PG is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
46
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $61.03. The Score for ARWR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PG Stock Price Chart
What is Procter & Gamble Co.'s stock price today?
-
The Procter & Gamble Co. share price today is $143.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PG is experiencing slight selling pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $61.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.
PG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.29 | Sell |
| Relative Strength Index (14 RSI): | 34.08 | Sell |
| Chaikin Money Flow: | -1950645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.25 - 157.07) | Sell |
| Bollinger Bands (100): | (142.25 - 156.07) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | -832975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.52 - 62.66) | Buy |
| Bollinger Bands (100): | (52.16 - 69.78) | Buy |
PG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 143.57 | Sell |
| 20-day SMA: | 147.57 | Sell |
| 50-day SMA: | 153.5 | Sell |
| 200-day SMA: | 152.01 | Sell |
| 8-day EMA: | 144.22 | Sell |
| 20-day EMA: | 147.38 | Sell |
| 50-day EMA: | 150.27 | Sell |
| 200-day EMA: | 152.99 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.99 | Buy |
| 20-day SMA: | 58.47 | Buy |
| 50-day SMA: | 62.54 | Sell |
| 200-day SMA: | 43.35 | Buy |
| 8-day EMA: | 60.24 | Buy |
| 20-day EMA: | 59.83 | Buy |
| 50-day EMA: | 60.7 | Buy |
| 200-day EMA: | 47.94 | Buy |
Procter & Gamble Co. Earnings Growth & PG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.32 per share, an increase this year of $0.20 per share, and an increase next year of $0.35 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.10 per share, a decrease this year of $3.21 per share, and a decrease next year of $1.06 per share.
Procter & Gamble Co. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||